XCSE
DAC
Market cap15mUSD
Apr 07, Last price
9.50DKK
1D
-3.06%
1Q
212.50%
IPO
61.02%
Name
Danish Aerospace Company A/S
Chart & Performance
Profile
Danish Aerospace Company A/S designs, develops, manufactures, and sells medical monitoring and exercise equipment. It offers agile data analyzer and monitor, a medical software that supports loading data over a network connection; portable pulmonary function systems for use in the areas of respiratory, cardiovascular, and metabolic physiology; cycle ergometer with vibration isolation and stabilization system, a recumbent bicycle that provides aerobic exercise for the harmful physiological effects of exposure to microgravity; advanced respiratory monitoring systems; European enhanced exploration exercise devices; space shuttle ergometer; and flight ergometer, the next generation space ergometer. The company also provides respiratory monitoring systems-II equipment, a photo- and magnetoacoustic multi-gas analyzer for performing non-invasive cardiovascular and pulmonary measurements; and European gas delivery system, a specially developed gas cylinder used for calibration and measurement of equipment and/or as breathing gases for use in space. Danish Aerospace Company A/S was founded in 1988 and is based in Odense, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
Income | |||||||
Revenues | 31,881 33.33% | 23,911 17.48% | |||||
Cost of revenue | 27,839 | 6,078 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 4,042 | 17,834 | |||||
NOPBT Margin | 12.68% | 74.58% | |||||
Operating Taxes | 694 | 675 | |||||
Tax Rate | 17.18% | 3.79% | |||||
NOPAT | 3,348 | 17,158 | |||||
Net income | 2,020 8.32% | 1,865 963.85% | |||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
Debt | |||||||
Debt current | 15,662 | 4,906 | |||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | 1,166 | 1,126 | |||||
Net debt | 15,563 | 4,775 | |||||
Cash flow | |||||||
Cash from operating activities | (8,944) | (6,371) | |||||
CAPEX | (36) | (1,112) | |||||
Cash from investing activities | (1,835) | (1,112) | |||||
Cash from financing activities | 10,756 | 4,906 | |||||
FCF | 5,462 | 7,789 | |||||
Balance | |||||||
Cash | 84 | 106 | |||||
Long term investments | 15 | 24 | |||||
Excess cash | |||||||
Stockholders' equity | 12,052 | 21,306 | |||||
Invested Capital | 28,879 | 27,339 | |||||
ROIC | 11.91% | 73.91% | |||||
ROCE | 12.95% | 55.94% | |||||
EV | |||||||
Common stock shares outstanding | 10,908 | 10,908 | |||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | 4,539 | 18,601 | |||||
EV/EBITDA | |||||||
Interest | 976 | 46 | |||||
Interest/NOPBT | 24.15% | 0.26% |